Overview
Willow Health offers weight management by prescribing GLP-1 medications (Semaglutide and Tirzepatide) through a subscription service. Members pay a monthly fee that covers the medication, FedEx 2-Day shipping, unlimited doctor messaging, free follow-ups, and injection supplies, with Semaglutide at $299 per month and Tirzepatide at $399–$524 per month depending on dosage. The treatment uses GLP-1 drugs to curb appetite and support weight loss, delivered via injections with ongoing remote medical support from board-certified doctors. Willow differentiates itself with clear, affordable pricing, easy enrollment, a supportive, non-judgmental approach, and integrated telemedicine and logistics within a single subscription to help people achieve sustainable weight loss.
Work here?Claim your company
Simplify's take
What believers are saying
- GLP-1 demand stays strong as patients seek cheaper access outside insurer restrictions.
- Willow's July 2026 claim retreat removes one legal overhang and reduces ad-platform risk.
- Oral semaglutide and tirzepatide expand convenience, which can improve retention and conversion.
What critics are saying
- Novo Nordisk challenged Willow's compounded semaglutide claims; July 24, 2026, Willow withdrew them.
- Compounding-heavy economics face FDA and pharmacy scrutiny; one adverse ruling can collapse demand.
- BBB rates Willow D; trust erosion can choke acquisition, refunds, and payer partnerships.
What makes Willow Health unique
- Willow pairs physician review with same-day online access and home delivery in 36 states.
- Willow sells compounded semaglutide, tirzepatide, and oral tablets, broadening route choice.
- Willow prices plans from $299 monthly, undercutting many cash-pay obesity clinics.
Help us improve and share your feedback! Did you find this helpful?